Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 923

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

The Dualistic Model of Ovarian Carcinogenesis

Open access
Kurman, Robert J., Shih, Ie-Ming·2016·The American Journal of Pathology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajpath.2015.11.011

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 93 references

Research works printed but not linked: 12

  1. Schmeler, 2010, Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary, Obstet Gynecol, 116, 269, 10.1097/AOG.0b013e3181e7961d · doi:10.1097/aog.0b013e3181e7961d
  2. Ardighieri, 2014, Shih IeM: Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants, J Pathol, 232, 16, 10.1002/path.4293 · doi:10.1002/path.4293
  3. Maniar, 2014, Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases, Am J Surg Pathol, 38, 743, 10.1097/PAS.0000000000000155 · doi:10.1097/pas.0000000000000155
  4. Silva, 1990, Ovarian carcinomas with transitional cell carcinoma pattern, Am J Clin Pathol, 93, 457, 10.1093/ajcp/93.4.457 · doi:10.1093/ajcp/93.4.457
  5. Ardighieri, 2014, Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants, J Pathol, 232, 16, 10.1002/path.4293 · doi:10.1002/path.4293
  6. Shappell, 2002, Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas, Am J Surg Pathol, 26, 1529, 10.1097/00000478-200212000-00001 · doi:10.1097/00000478-200212000-00001
  7. Cuatrecasas, 1997, K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases, Cancer, 79, 1581, 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T · doi:10.1002/(sici)1097-0142(19970415)79:8<1581::aid-cncr21>3.0.co;2-t
  8. Wang, 2015, Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin, J Pathol, 237, 146, 10.1002/path.4572 · doi:10.1002/path.4572
  9. Piek, 2001, Tubal ligation and risk of ovarian cancer, Lancet, 358, 844, 10.1016/S0140-6736(01)05992-X · doi:10.1016/s0140-6736(01)05992-x
  10. Gagner, 2005, Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma, Gynecol Oncol, 97, 219, 10.1016/j.ygyno.2004.11.053 · doi:10.1016/j.ygyno.2004.11.053
  11. Bijron, 2013, Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis, Am J Surg Pathol, 37, 1123, 10.1097/PAS.0b013e318282da7f · doi:10.1097/pas.0b013e318282da7f
  12. Wethington, 2013, Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC), Int J Gynecol Cancer, 23, 1603, 10.1097/IGC.0b013e3182a80ac8 · doi:10.1097/igc.0b013e3182a80ac8

Cited by

See all 923

Metadata

Authors
Kurman, R. J., & Shih, I.-M.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2016-04
Volume
186
Issue
4
Pages
733-747
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2305551225
Cited by
923
References
93
FWCI
111.25
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Dualistic Model of Ovarian Carcinogenesis. https://app.cochat.ai/papers/10.1016/j.ajpath.2015.11.011
The paper
Kurman, R. J., & Shih, I.-M. (2016). The Dualistic Model of Ovarian Carcinogenesis. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2015.11.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.